Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 1/20 | 0.56 |
| ▸ | LDHA | P00338 | 1/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | MMP1 | P03956 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.45 |
| ▸ | ADRB2 | P07550 | 4/20 | 0.44 |
| ▸ | IDO1 | P14902 | 1/20 | 0.44 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29226627 | 0.82 | CA1 (0.59) | SLC6A4IDO1ADRB3CYP2C9TSHR | |
| SCHEMBL28714838 | 0.81 | SLC6A4 (0.60) | SLC6A4LDHACYP2D6CYP1A2CYP2C19 | |
| SCHEMBL1815225 | 0.81 | POLB (0.57) | SLC6A4LDHACYP2D6CYP1A2CYP2C19 | |
| SCHEMBL7976221 | 0.81 | SLC6A4 (0.60) | SLC6A4LDHACYP2D6CYP1A2CYP2C19 | |
| SCHEMBL4373460 | 0.81 | LDHA (0.56) | SLC6A4LDHACYP2D6CYP1A2CYP2C19 | |
| SCHEMBL8283102 | 0.81 | SLC6A4 (0.60) | SLC6A4LDHACYP2D6CYP1A2CYP2C19 | |
| SCHEMBL2941975 | 0.80 | SLC6A4 (0.64) | SLC6A4LDHACYP2D6CYP1A2CYP2C19 | |
| SCHEMBL2666118 | 0.80 | SLC6A4 (0.64) | SLC6A4LDHACYP2D6CYP1A2CYP2C19 | |
| SCHEMBL2428966 | 0.80 | SLC6A4 (0.64) | SLC6A4LDHACYP2D6CYP1A2CYP2C19 | |
| SCHEMBL4437952 | 0.79 | TRPA1 (0.59) | SLC6A4CYP2D6CYP1A2CYP3A4IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220276257-A1 | Modular Chemical Probe For Detection Of Amino Acid Citrulline In Physiological Samples | WISYS TECH FOUNDATION INC (US) | 2022-09-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220276257-A1 | Modular Chemical Probe For Detection Of Amino Acid Citrulline In Physiological Samples | PADI3, PADI2, PADI1 | SLC6A4 2995/4885LDHA 515/4885CYP2D6 3566/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.